Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II StudyAndrew X. Zhu, Dan G. Duda, Emmanuelle di Tomaso et al.|Journal of Clinical Oncology|2009Cited by 476
A phase II study of sunitinib in patients with advanced hepatocellular carcinomaAndrew X. Zhu, D. Sahani, Emmanuelle di Tomaso et al.|Journal of Clinical Oncology|2007Cited by 55